About: http://data.cimple.eu/news-article/86393882407f36e85f1840ed379a61364e72d6f7c5c3da805bce5774

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/86393882407f36e85f1840ed379a61364e72d6f7c5c3da805bce5774 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	The doctor who treated the first COVID-19 patient in the United States said Monday he fears a second outbreak of the disease when lockdown measures are lifted. George Díaz's first patient, diagnosed in January in Washington state, has already recovered after receiving remdesivir, an experimental drug that the US approved on Friday for emergency use. While he feels encouraged by this anti-viral, Diaz emphasized that isolation to avoid contagion remains the "most effective" treatment for COVID-19 right now. Since that first case in January, the US has overtaken all other countries to have by far the highest caseload -- about 1.2 million -- as well as the most deaths, around 69,000. Despite forecasts of a worsening death toll, some states are already reopening to try to ease the economic strain of shelter-in-place orders that have put more than 30 million Americans out of work in six weeks. "What worries me is that when the economy starts to reopen, we are going to see a second outbreak that is perhaps as big as the first, and the first one was very difficult for us and for the whole world," Díaz told reporters during a video meeting organized by the State Department. "And more than anything, I am concerned that I don't know if we are going to have the resources to handle a second outbreak," he added. Remdesivir, made by Gilead Sciences, was shown in a major clinical trial to shorten the time to recovery in some coronavirus patients. Diaz said that, pending development of a vaccine, remdesivir appears to act against the virus, but he cautioned that the drug must be used very wisely. It should not be a crutch for people to say, "'I can now do whatever I want because we have a treatment.' No," Diaz warned. They must continue to follow guidance on social distancing, he said. ad/it/to
schema:headline	Doctor who treated first US COVID patient fears second wave
schema:mentions	Clinical trial Remdesivir University of Washington Ebola virus disease Social distancing Lockdown Coronavirus disease Vaccine United States Severe acute respiratory syndrome coronavirus 2 Twelfth Doctor Gilead Sciences
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-05-05 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	73 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software